Lomustine

Welcome to Dwaey, specifically on Lomustine page.
This medicine contains important and useful components, as it consists of
Lomustine is available in the market in concentration.

Generic Name of Lomustine - Learn More

Lomustine

Lomustine Precaution - What You Need to Know

Lomustine (also known as CCNU) is a chemotherapy agent used in the treatment of various cancers, including brain tumors, Hodgkin lymphoma, and non-Hodgkin lymphoma. It is important to take certain precautions when using this medication, as it can cause severe side effects, especially when used in special populations:

- Pregnancy and Breastfeeding: Lomustine is classified as a Category D drug for pregnancy, meaning it may harm an unborn baby. It should only be used if absolutely necessary, and alternative treatments should be considered. It is not recommended for use during breastfeeding, as it can be excreted in breast milk and harm the infant.
- Bone Marrow Suppression: Lomustine can cause myelosuppression (reduced bone marrow function), leading to neutropenia, thrombocytopenia, and anemia. Frequent blood tests to monitor the patient’s blood cell counts are necessary, particularly before each cycle of chemotherapy.
- Liver and Kidney Function: It may affect liver and kidney function, so careful monitoring of liver enzymes and renal function is required during therapy, particularly in patients with pre-existing liver or kidney conditions.
- Secondary Malignancies: There is a risk of developing secondary cancers, including leukemia, after prolonged or repeated treatment with lomustine.

Monitoring Parameters:
- Regular complete blood counts (CBC) are necessary to monitor for signs of myelosuppression.
- Liver function tests (e.g., AST, ALT, bilirubin) and renal function tests (e.g., serum creatinine, blood urea nitrogen) should be conducted routinely.
- Pulmonary function should also be monitored if long-term therapy is anticipated due to the potential for lung toxicity.

Misuse/Dependency:
Lomustine is not addictive or commonly associated with misuse. However, it is a potent chemotherapy agent, and improper handling or administration could result in serious side effects or harm to the patient. It should only be used under the supervision of a healthcare provider experienced in chemotherapy treatments.

---

Lomustine Indication - Uses and Benefits

Lomustine is primarily used in the treatment of cancer, specifically in the following indications:

- Brain Tumors: Lomustine is widely used to treat gliomas, including glioblastomas and astrocytomas. It is often used in combination with other treatments, such as radiation, to manage these malignancies.
- Hodgkin’s Lymphoma: It is used as part of a combination chemotherapy regimen for the treatment of Hodgkin lymphoma, particularly in cases that are resistant to first-line treatments.
- Non-Hodgkin’s Lymphoma: Lomustine is also used in the treatment of non-Hodgkin lymphoma, especially in cases where the disease is refractory or relapsed.
- Other Cancers: It may be used off-label in other cancers, such as melanoma, small cell lung cancer, and some forms of leukemia, when other therapies have not been effective.

Lomustine is often given as part of a combination chemotherapy regimen, which may include other agents like carmustine, vincristine, or prednisone, depending on the specific malignancy.

---

Lomustine Contraindications - Important Warnings

There are several conditions that would exclude a patient from safely using lomustine:

- Hypersensitivity: Any history of allergic reactions or hypersensitivity to lomustine or other nitrosoureas (such as carmustine) would be a contraindication.
- Severe Bone Marrow Suppression: Lomustine should not be used in patients with severe bone marrow suppression or those who have a history of chemotherapy-induced myelosuppression.
- Severe Liver Disease: Patients with severe liver disease should avoid lomustine due to the risk of liver toxicity and further liver impairment.
- Active Infection: Infections should be treated and resolved before starting lomustine therapy, as it can further compromise the immune system and increase susceptibility to infections.
- Pregnancy: Lomustine is contraindicated during pregnancy due to its teratogenic effects. Women who are pregnant or planning to become pregnant should avoid this medication.

Age Restrictions: Lomustine is generally safe for use in adults, but its use in pediatric patients is limited. It may be used off-label in children with specific types of cancer, but this should be approached with caution.

---

Lomustine Side Effects - What to Expect

Lomustine carries a range of side effects, both short-term and long-term:

- Common Side Effects:
- Nausea and Vomiting: These are common and can be managed with antiemetic medications.
- Myelosuppression: Decreased red and white blood cell counts can lead to anemia, neutropenia, and thrombocytopenia, increasing the risk of infections, fatigue, and bleeding.
- Liver Toxicity: Elevated liver enzymes (AST, ALT) can be indicative of liver damage, and regular monitoring is essential.

- Serious Side Effects:
- Pulmonary Toxicity: Long-term use of lomustine can lead to lung fibrosis or pulmonary toxicity, which can be fatal.
- Secondary Malignancies: Patients treated with lomustine are at an increased risk for developing secondary cancers, particularly leukemia, years after treatment.
- Renal Toxicity: Some patients may experience renal impairment, requiring close monitoring of kidney function.

Management of Side Effects:
- Supportive Care: Antiemetic drugs can help manage nausea and vomiting, and growth factors like G-CSF (granulocyte-colony stimulating factor) may be used to counteract neutropenia.
- Regular Monitoring: Liver, kidney, and blood function should be monitored closely during treatment to detect any signs of toxicity early.

---

Lomustine Pregnancy Category ID - Safety Information

4

Lomustine Mode of Action - How It Works

Lomustine is an alkylating agent that works by cross-linking DNA strands, thereby preventing the DNA from unwinding and replicating. This inhibits the synthesis of new DNA and causes cell death. It specifically targets tumor cells, which are rapidly dividing, making it effective for cancer treatment.

- Pharmacodynamics: Lomustine interferes with the synthesis of nucleic acids by alkylating the guanine residue in DNA, resulting in cross-linking between DNA strands. This ultimately leads to DNA strand breakage and the inhibition of cell division, especially in rapidly proliferating cancer cells.
- Pharmacokinetics: Lomustine is well absorbed when administered orally and is distributed throughout the body, including the central nervous system. It is metabolized by the liver and has a long half-life, which allows for once-a-week dosing in most patients.

---

Lomustine Drug Interactions - What to Avoid

Lomustine can interact with several other drugs, which may alter its effectiveness or increase the risk of side effects:

- Other Chemotherapy Agents: Lomustine can interact with other chemotherapeutic drugs, such as cyclophosphamide, vincristine, and doxorubicin, potentially increasing the risk of myelosuppression, gastrointestinal toxicity, and infections.
- Phenytoin: There is a potential for reduced effectiveness of lomustine when used with phenytoin, as phenytoin can alter the drug metabolism in the liver.
- Live Vaccines: Patients undergoing treatment with lomustine should avoid live vaccines, as their immune system may be too compromised to respond to the vaccine effectively.

Food and Alcohol Interactions:
- Alcohol: Alcohol can exacerbate the side effects of lomustine, particularly the risk of liver toxicity and gastrointestinal disturbances. It is advisable to avoid alcohol during treatment.
- Food: There are no significant food interactions with lomustine. However, due to its gastrointestinal side effects, taking the medication with food may help reduce nausea or vomiting.

---

Lomustine Adult Dose - Recommended Dosage

For adult patients, the standard dosage of lomustine is:

- Standard Dose: Lomustine is typically administered as a single oral dose once every 6 weeks. The dose varies depending on the specific type of cancer being treated but generally ranges from 100 mg/m² to 130 mg/m² per cycle.
- Dosing Schedule: Lomustine is given in cycles, with the dose being repeated every 6 weeks. The exact dosing schedule may vary based on the patient's response and side effects.

Maximum Dose: The maximum dose should not exceed 130 mg/m² per cycle.

---

Lomustine Child Dose - Dosage for Children

For pediatric patients, the dosing of lomustine is individualized based on the type of cancer and the child's overall health. The typical dose for children is similar to that for adults but requires close monitoring due to the potential for toxicity:

- Pediatric Dosing: Typically, doses are based on body surface area (BSA), generally around 100 mg/m² once every 6 weeks. However, the exact dose and schedule should be determined by the oncologist, considering the child’s condition and response to treatment.

Lomustine Renal Dose - Dosage for Kidney Conditions

In patients with renal impairment, lomustine should be used with caution:

- Mild to Moderate Renal Impairment: No specific dose adjustment is typically required for mild to moderate renal impairment, but close monitoring is necessary.
- Severe Renal Impairment: In cases of severe renal impairment, lomustine should be used cautiously, and dose reduction may be considered. Monitoring of renal function is essential.

---